Role of the ABCG8 19H risk allele in cholesterol absorption and gallstone disease

BMC Gastroenterology

Volumn 13, Issue 1, 2013, Pages

  Renner, Olga ^a   Lütjohann, Dieter ^b   Richter, Dominique ^a   Strohmeyer, André ^a   Schimmel, Silke ^a   Müller, Oliver ^c   Stange, Eduard F ^c   Harsch, Simone ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER G1; CAMPESTEROL; CELL PROTEIN; CHOLESTEROL; GENOMIC DNA; LATHOSTEROL; MESSENGER RNA; NIEMANN PICK C1 LIKE 1 PROTEIN; PHYTOSTEROL; SITOSTEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATP BINDING CASSETTE TRANSPORTER 8 GENE; CHOLELITHIASIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; LIPID ABSORPTION; MASS FRAGMENTOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ATP-BINDING CASSETTE TRANSPORTERS; BIOPSY; CHOLESTEROL; FEMALE; GALLSTONES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ILEUM; INTESTINAL ABSORPTION; MALE; MIDDLE AGED; PHYTOSTEROLS; POLYMORPHISM, GENETIC; RISK FACTORS; SITOSTEROLS; STEROLS;

EID: 84874730415     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-13-30     Document Type: Article

References (63)

1. Schafmayer C, Hartleb J, Tepel J, Albers S, Freitag S, Voelzke H, Buch S, Seeger M, Timm B, Kremer B, Foelsch UR, Fändrich F, Krawczyk M, Schreiber S, Hampe J. Predictors of gallstone composition in 1.025 symptomatic gallstones from Northern Germany. BMC Gastroenterol 2006, 6:36.
2. Wang DQ, Carey MC. Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing systems. J Lipid Res 1996, 37(3):606-630.
3. Kern F. Effects of dietary cholesterol on cholesterol and bile acid homeostasis in patients with cholesterol gallstones. J Clin Invest 1994, 93:1186-1189.
4. Krawczyk M, Lütjohann D, Schirin-Sokhan R, Villarroel L, Nervi F, Pimentel F, Lammert F, Miquel F. Phytosterol and cholesterol precursor levels indicate increased cholesterol excretion and biosynthesis in gallstone patients. Hepatology 2012, 55(5):1507-1517.
5. Turley SD, Dietschy JM. The contribution of newly synthesized cholesterol to biliary cholesterol in the rat. J Biol Chem 1981, 256(5):2438-2446.
6. Scheibner J, Fuchs M, Schiemann M, Tauber G, Hörmann E, Stange EF. Bile acid synthesis from newly synthesized vs. preformed cholesterol precursor pools in the rat. Hepatology 1993, 17(6):1095-1102.
7. Scheibner J, Fuchs M, Hörmann E, Tauber G, Stange EF. Biliary cholesterol secretion and bile acid formation in the hamster: the role of newly synthesized cholesterol. J Lipid Res 1994, 35(4):690-697.
8. Empen K, Lange K, Stange EF, Scheibner J. Newly synthesized cholesterol in human bile and plasma: quantitation by mass isotopomer distribution analysis. Am J Physiol 1997, 272(2 Pt 1):G367-G373.
9. Klass DM, Bührmann K, Sauter G, Del Puppo M, Scheibner J, Fuchs M, Stange EF. Biliary lipids, cholesterol and bile synthesis: different adaptive mechanisms to dietary cholesterol in lean and obese subjects. Aliment Pharmacol Ther 2006, 23(7):895-905.
10. Berr F, Pratschke E, Fischer S, Paumgartner G. Disorders of bile acid metabolism in cholesterol gallstone disease. J Clin Invest 1992, 90(3):859-868.
11. Shoda J, He BF, Tanaka N, Matsuzaki Y, Osuga T, Yamamori S, Miyazaki H, Sjoevall J. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit. Hepatology 1995, 21(5):1291-1302.
12. Bergheim I, Harsch S, Mueller O, Schimmel S, Fritz P, Stange EF. Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers. J Lipid Res 2006, 47(1):42-50.
13. Renner O, Harsch S, Strohmeyer A, Schimmel S, Stange EF. Reduced ileal expression of OSTalpha OSTbeta in non-obese gallstone disease. J Lipid Res 2008, 49(9):2045-2054.
14. LaMont JT, Carey MC. Cholesterol gallstone formation. 2. Pathobiology and pathomechanics. Prog Liver Dis 1992, 10:165-191.
15. Altmann SW, Davis HR, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Gtatiano MP. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 2004, 303(5661):1201-1204.
16. Sané AT, Sinnett D, Delvin E, Bendayan M, Marcil V, Ménard D, Beaulieu J-F, Levy E. Localization and role of NPC1L1 in cholesterol absorption in human intestine. J Lipid Res 2006, 47(10):2112-2120.
17. Davis HR, Zhu LJ, Hoos LM, Tetzloff G, Maguire M, Liu J, Yao X, Iyer SP, Lam M-H, Lund EG, Detmers PA, Graziano MP, Altmann SW. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem 2004, 279(32):33586-33592.
18. Duval C, Touche V, Tailleux A, Fruchart JC, Fievet C, Clavey V, Staels B, Lestavel S. Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine. Biochem Biophys Res Commun 2006, 340(4):1259-1263.
19. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, Kojima H, Allikmets R, Sakuma N, Pegoraro R, Srivastava AK, Salen G, Dean M, Patel SB. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001, 27(1):79-83.
20. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, Hobbs HH. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 2002, 110(5):671-680.
21. Kosters A, Frijters RJ, Schaap FG, Vink E, Plösch T, Ottenhoff R, Jirsa M, De Cuyper IM, Kuipers F, Groen AK. Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice. J Hepatol 2003, 38(6):710-716.
22. Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 2002, 277(21):18793-18800.
23. Pramfalk C, Jiang ZY, Cai Q, Hu H, Zhang SD, Han TQ, Eriksson M, Parini P. HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liver. J Lipid Res 2010, 51(6):1354-1362.
24. van der Veen JN, Kruit JK, Havinga R, Baller JF, Chimini G, Lestavel S, Staels B, Groot PH, Groen AK, Kuipers F. Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. J Lipid Res 2005, 46(3):526-534.
25. Iwayanagi Y, Takada T, Suzuki H. HNF4alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1. Pharm Res 2008, 25(5):1134-1141.
26. Wittenburg H, Lyons MA, Paigen B, Carey MC. Mapping cholesterol gallstone susceptibility (Lith) genes in inbred mice. Dig Liver Dis 2003, 35:S2-S7.
27. Wittenburg H, Lyons MA, Li R, Churchill GA, Carey MC, Paigen B. FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice. Gastroenterology 2003, 125(3):868-881.
28. Katsika D, Grjibovski A, Einarsson C, Lammert F, Lichtenstein P, Marschall HU. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology 2005, 41(5):1138-1143.
29. Buch S, Schafmayer C, Völzke H, Becker C, Franke A, von Eller-Eberstein H, Kluck C, Bässmann I, Brosch M, Lammert F, Miquel JF, Nervi F, Wittig M, Rosskopf D, Timm B, Höll C, Seeger M, ElSharawy A, Lu T, Egberts J, Faendrich F, Foelsch UR, Krawczak M, Schreiber S, Nürnberg P, Tepel J, Hampe J. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007, 39(8):995-999.
30. Berge KE, von Bergmann K, Lutjohann D, Guerra R, Grundy SM, Hobbs HH, Cohen JC. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res 2002, 43(3):486-494.
31. Gylling H, Hallikainen M, Pihlajamäki J, Agren J, Laakso M, Rajaratnam RA, Rauramaa R, Miettinen TA. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J Lipid Res 2004, 45(9):1660-1665.
32. Sudhop T, Lütjohann D, Kodal A, Igel M, Tribble DL, Shah S, Perevozskaya I, von Bergmann K. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 2002, 106(15):1943-1948.
33. Miettinen TA, Tilvis RS, Kesaeniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990, 131(1):20-31.
34. Renner O, Harsch S, Schaeffeler E, Schwab M, Klass DM, Kratzer W, Stange EF. Mutation screening of apical sodium-dependent bile acid transporter (SLC10A2): novel haplotype block including six newly identified variants linked to reduced expression. Hum Genet 2009, 125(4):381-391.
35. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005, 76(5):887-893.
36. Zamboni M, Mazzali G, Zoico E, Harris TB, Meigs JB, Di Francesco V, Fantin F, Bissoli L, Bosello O. Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond) 2005, 29(9):1011-1029.
37. Donini LM, Savina C, Cannella C. Eating habits and appetite control in the elderly: the anorexia of aging. Int Psychogeriatr 2003, 15(1):73-87.
38. Lechleitner M. Obesity and the metabolic syndrome in the elderly-a mini-review. Gerontology 2008, 54(5):253-259.
39. Kuczmarski RJ, Flegal KM. Criteria for definition of overweight in transition: background and recommendations for the United States. Am J Clin Nutr 2000, 72(5):1074-1081.
40. Babiarczyk B, Turbiarz A. Body Mass Index elderly people - reference ranges matter. Prog Health Sci 2012, 2(1):58-67.
41. Grünhage F, Acalovschi M, Tirziu S, Walier M, Wienker TF, Ciocan A, Mosteanu O, Sauerbruch T, Lammert F. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol. Hepatology 2007, 46(3):793-801.
42. Simonen PP, Gylling H, Miettinen T. Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics. Obes Res 2002, 10(5):328-335.
43. Gylling H, Hallikainen M, Kolehmainen M, Toppinen L, Pihlajamäki J, Mykkänen H, Agren JJ, Rauramaa R, Laakso M, Miettinen TA. Cholesterol synthesis prevails over absorption in metabolic syndrome. Transl Res 2007, 149(6):310-316.
44. Nakeeb A, Comuzzie AG, Martin L, Sonnenberg GE, Swartz-Basile D, Kissebah AH, Pitt HA. Gallstones: genetics versus environment. Ann Surg 2002, 235(6):842-849.
45. Wilund KR, Feeney LA, Tomayko EJ, Weiss EP, Hagberg JM. Effects of endurance exercise training on markers of cholesterol absorption and synthesis. Physiol Res 2009, 58(4):545-552.
46. Miettinen TA, Gylling H. Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis 2000, 153(1):241-248.
47. Duan LP, Wang HH, Wang DQ. Cholesterol absorption is mainly regulated by the jejunal and ileal ATP-binding cassette sterol efflux transporters Abcg5 and Abcg8 in mice. J Lipid Res 2004, 45(7):1312-13123.
48. Wang HH, Patel SB, Carey MC, Wang DQ. Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8(-/-) mice. Hepatology 2007, 45(4):998-1006.
49. Wang DQ, Zhang L, Wang HH. High cholesterol absorption efficiency and rapid biliary secretion of chylomicron remnant cholesterol enhance cholelithogenesis in gallstone-susceptible mice. Biochim Biophys Acta 2005, 1733(1):90-99.
50. Jiang ZY, Parini P, Eggertsen G, Davis MA, Hu H, Suo GJ, Zhang SD, Rudel LL, Han TQ, Einarsson C. Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients. J Lipid Res 2008, 49(2):464-472.
51. Kamisako T, Ogawa H. Regulation of biliary cholesterol secretion is associated with abcg5 and abcg8 expressions in the rats: effects of diosgenin and ethinyl estradiol. Hepatol Res 2003, 26(4):348-352.
52. Yu L, von Bergmann K, Lütjohann D, Hobbs HH, Cohen JC. Selective sterol accumulation in ABCG5/ABCG8-deficient mice. J Lipid Res 2004, 45(2):301-307.
53. Masson CJ, Plat J, Mensink RP, Namiot A, Kisielewski W, Namiot Z, Füllekrug J, Ehehalt R, Glatz JF, Pelsers MM. Fatty acid- and cholesterol transporter protein expression along the human intestinal tract. PLoS One 2010, 5(4):e10380.
54. Hirata T, Okabe M, Kobayashi A, Ueda K, Matsuo M. Molecular mechanisms of subcellular localization of ABCG5 and ABCG8. Biosci Biotechnol Biochem 2009, 73(3):619-626.
55. Jiang ZY, Jiang CY, Wang L, Wang JC, Zhang SD, Einarsson C, Eriksson M, Han TQ, Parini P, Eggertsen G. Increased NPC1L1 and ACAT2 expression in the jejunal mucosa from Chinese gallstone patients. Biochem Biophys Res Commun 2009, 379(1):49-54.
56. Cui W, Jiang ZY, Cai Q, Zhang RY, Wu WZ, Wang JC, Fei J, Zhang SD, Han TQ. Decreased NPC1L1 expression in the liver from Chinese female gallstone patients. Lipids Health Dis 2010, 9:17.
57. Stender S, Frikke-Schmidt R, Nordestgaard BG, Tybjaerg-Hansen A. Sterol transporter adenosine triphosphate-binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population. Hepatology 2011, 53(2):640-648.
58. Xu HL, Cheng JR, Andreotti G, Gao YT, Rashid A, Wang BS, Shen MC, Chu LW, Yu K, Hsing AW. Cholesterol metabolism gene polymorphisms and the risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China. Carcinogenesis 2011, 32(1):58-62.
59. Srivastava A, Srivastava A, Srivastava K, Choudhuri G, Mittal B. Role of ABCG8 D19H (rs11887534) variant in gallstone susceptibility in northern India. J Gastroenterol Hepatol 2010, 25(11):1758-1762.
60. Siddapuram SP, Mahurkar S, Duvvuru NR, Mitnala S, Guduru VR, Rebala P, Mansard MJ. Hepatic cholesterol transporter ABCG8 polymorphisms in gallstone disease in an Indian population. J Gastroenterol Hepatol 2010, 25(6):1093-1098.
61. Kuo KK, Shin SJ, Chen ZC, Yang YH, Yang JF, Hsiao PJ. Significant association of ABCG5 604Q and ABCG8 D19H polymorphisms with gallstone disease. Br J Surg 2008, 95(8):1005-1011.
62. Acalovschi M, Ciocan A, Mostean O, Tirziu S, Chiorean E, Keppeler H, Schirin-Sokhan R, Lammert F. Are plasma lipid levels related to ABCG5/ABCG8 polymorphisms? A preliminary study in siblings with gallstones. Eur J Intern Med 2006, 17(7):490-494.
63. Chen ZC, Shin SJ, Kuo KK, Lin KD, Yu ML, Hsiao PJ. Significant association of ABCG8:D19H gene polymorphism with hypercholesterolemia and insulin resistance. J Hum Genet 2008, 53(8):757-763.